PLRZ · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus · Market Cap: $0.0B · 1 employees
55
SEC Filings
$15.31
Close 2026-07-23
1
Employees
Business Summary
Polyrizon Ltd. is an Israeli-based clinical-stage medical technology company developing novel biopolymer-based product candidates. The company focuses on two main technology platforms: C&C (Capture and Combat) and T&T (Trap and Treat), with lead product PL-16 being pursued as a Class II medical device via FDA de novo classification. Polyrizon has not generated any revenue from product sales and continues to incur significant losses since inception.
Look up PLRZ using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on PLRZ, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/PLRZ (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.